Neoadjuvant Concomitant Modulated Electro-hyperthermia in HER2-negative Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: HER2-negative Breast Cancer
Interventions: DEVICE: Oncotherm EHY-2030|DRUG: Paclitaxel|DRUG: Carboplatin|DRUG: Cyclophosphamide/Doxorubicin|PROCEDURE: Breast cancer removal surgery
Sponsor: Semmelweis University